Drug Interaction — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Fluconazole inhibits CYP2C9, reducing warfarin metabolism
Fluconazole is a potent inhibitor of CYP2C9, the primary enzyme responsible for the metabolism of the more active S-enantiomer of warfarin. This results in markedly elevated INR. The interaction is predictable and dose-dependent. If fluconazole is necessary, the warfarin dose should be reduced by ~25–50% with frequent INR monitoring.
Reference: AMH – 2025 – Drug Interactions; eTG – 2025 – Antimicrobials